NASDAQ
3.04USD
+0.22 (+7.80%)
We have scored 4 news catalysts on SAB Biotherapeutics, Inc. (SABS) over the past 12 months. The biggest single-day move next to one of them came Dec 8, 2025, when SABS closed −10.8%: “SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management”. Coverage across the window leans positive (average ticker sentiment +0.47). Most of the impact sits in price momentum and sector healthcare.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
276.6M
P/E
—
EPS
—
Beta
0.58
52W range
2.44-5.15
Day range
2.83–3.08
Open
2.83
Prev close
2.82
Volume
710.2K
Avg volume
686K
Dividend
0.00
IPO
2021-02-09
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about SAB Biotherapeutics, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for SABS: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.
